-
Press Release
Novartis receives approval for first malaria medicine for newborn babies and young infants
-
Story
Renewing our commitment to neglected tropical disease and malaria elimination -
Story
Staying one step ahead of the malaria parasite -
Press Release
Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease
-
Press Release
Novartis global survey uncovers profound and often under-reported effects on sickle cell disease patients
-
Story
New drugs could offer hope for malaria patients -
Story
Malaria fighter rides bicycle into battle with disease -
Story
A life dedicated to fighting malaria -
Story
Opening chemistry education to the world -
Story
Killing three diseases with one stone in the lab -
Story
Experimental treatment clears malaria infections in small clinical study